Crystal structure of the catalytic domain of human adam33 Deposition Author(s): Hammond, G. , Mirza, U.A. , Orth, P. , Prosise, W.W. , Reicher, P. , Strickland, C. , Taremi, S.S. , Wang, W. , Xiao, L. , Yarosh-Tomaine, T. , Zou, J.
Date: 2003-10-09 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Homo Sapiens Sequences Data: 1R54_A
Crystal structure of the catalytic domain of human adam 33 Deposition Author(s): Hammond, G. , Le, H.V. , Madison, V. , Mirza, U.A. , Orth, P. , Prosise, W.W. , Reichert, P. , Strickland, C. , Taremi, S.S. , Wang, W. , Xiao, L. , Yarosh-Tomaine, T. , Zou, J.
Date: 2003-10-09 Method: X-RAY DIFFRACTION Resolution: 1.58 Å Organism(s): Homo Sapiens Sequences Data: 1R55_A
Crystal structure of biotin carboxylase from e. coli in complex with benzimidazole series Deposition Author(s): Black, T. , Cheng, C. , Kawahata, N. , Mann, P. , Orth, P. , Shipps, G.W. , Soriano, A. , Soucy, K. , Sun, B. , Xiao, L. , Yang, Z.
Date: 2009-09-23 Method: X-RAY DIFFRACTION Resolution: 2.31 Å Organism(s): Escherichia Coli Sequences Data: 3JZI_A , 3JZI_B
Discovery of orally active pyrazoloquinoline as a potent pde10 inhibitor for the management of schizophrenia Deposition Author(s): Greenlee, W.J. , Ho, G. , Hodgson, R. , Hruza, A. , Mcelroy, W. , Smotryski, J. , Tulshian, D. , Xiao, L. , Yang, S.
Date: 2011-11-04 Method: X-RAY DIFFRACTION Resolution: 2.28 Å Organism(s): Homo Sapiens Sequences Data: 3UI7_A , 3UI7_B
The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as pde10 inhibitors for the treatment of schizophrenia Deposition Author(s): Bercovici, A. , Bleickardt, C. , Greenlee, W.J. , Guzzi, M. , Ho, G.D. , Hodgson, R. , Hruza, A. , Mcelroy, W. , Mckittrick, B. , Mullins, D. , Nechuta, T. , Rindgen, D. , Smith, E.M. , Smotryski, J. , Tan, Z. , Tulshian, D. , Xiao, L. , Yang, S. , Zhang, X.
Date: 2011-11-28 Method: X-RAY DIFFRACTION Resolution: 2.11 Å Organism(s): Homo Sapiens Sequences Data: 3UUO_A , 3UUO_B
The sar development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10a inhibitors for the treatment of schizophrenia Deposition Author(s): Bercovici, A. , Bleichardt, C. , Greenlee, W.J. , Guzzi, M. , Ho, G.D. , Hodgson, R. , Hruza, A. , Mullins, D. , Rindgen, D. , Seganish, W.M. , Tulshian, D. , Van Rijn, R. , Xiao, L. , Zhang, X.
Date: 2012-01-23 Method: X-RAY DIFFRACTION Resolution: 2.11 Å Organism(s): Homo Sapiens Sequences Data: 4DFF_A , 4DFF_B
Clostridium difficile toxin b crop domain in complex with fab domains of neutralizing antibody bezlotoxumab Deposition Author(s): Beaumont, M. , Dinunzio, E. , Ermakov, G. , Hernandez, L.D. , Ingram, R.N. , Karczewski, J. , Mayhood, T. , Murgolo, N. , Orth, P. , Racine, F. , Reichert, P. , Secore, S. , Sheth, P. , Strickland, C. , Therien, A.G. , Xiao, L.
Date: 2013-11-20 Method: X-RAY DIFFRACTION Resolution: 2.89 Å Organism(s): Clostridium Difficile , Homo Sapiens Sequences Data: 4NP4_A , 4NP4_H , 4NP4_I , 4NP4_L , 4NP4_M
Discovery of novel, dual mechanism erk inhibitors by affinity selection screening of an inactive kinase state Deposition Author(s): Annis, D.A. , Carr, D. , Chuang, C. , Cooper, A. , Dayananth, P. , Deng, Y. , English, J.M. , Hruza, A.W. , Jin, W. , Kirschmeier, P. , Nan, Y. , Samatar, A.A. , Shipps, G.W. , Wang, T. , Windsor, W.T. , Xiao, L. , Zhu, Y.H.
Date: 2014-07-26 Method: X-RAY DIFFRACTION Resolution: 1.65 Å Organism(s): Rattus Norvegicus Sequences Data: 4QYY_A
Discovery of mli-2, an orally available and selective lrrk2 inhibitor that reduces brain kinase activity Deposition Author(s): Agnihotri, G. , Baptista, M. , Basu, K. , Chang, R.K. , Columbus, J. , Dai, X. , Demong, D.E. , Drolet, R.E. , Embrey, M.W. , Fell, M.J. , Greshock, T.J. , Harris, J. , Hruza, A. , Kennedy, M.E. , Kern, J.T. , Li, W. , Lin, S. , Lin, Y. , Liu, H. , Mccauley, J.A. , Mei, H. , Miller, M.W. , Mirescu, C. , Morrow, J.A. , Nargund, R. , Parker, E.M. , Poirier, M. , Sanders, J.M. , Scott, J.D. , Stamford, A.W. , Tiscia, H.E. , Xiao, L. , Yin, Z. , Zhou, X.
Date: 2016-12-08 Method: X-RAY DIFFRACTION Resolution: 1.69 Å Organism(s): Rattus Norvegicus Sequences Data: 5U6I_A
Discovery of mk-8353: an orally bioavailable dual mechanism erk inhibitor for oncology Deposition Author(s): Alhassan, A.B. , Bishop, R. , Boga, S.B. , Buevich, A. , Carr, D. , Cooper, A. , Cox, K. , Dayananth, P. , Deng, Y. , Desai, J. , Doll, R. , Gao, X. , Gudipati, S. , Hesk, D. , Hruza, A.W. , Jin, W. , Kelly, J. , Kirschmeier, P. , Liu, G. , Long, B. , Mei, H. , Muppalla, K. , Nan, Y. , Paliwal, S. , Patel, M. , Samatar, A.A. , Sherborne, B. , Shih, N. , Shipps Jr., G.W. , Sun, R. , Taylor, S.A. , Tsui, H. , Wang, J. , Wang, T. , Windsor, W.T. , Xiao, L. , Yao, X. , Zhang, L. , Zhu, H. , Zhu, L.
Date: 2018-05-06 Method: X-RAY DIFFRACTION Resolution: 1.45 Å Organism(s): Rattus Norvegicus Sequences Data: 6DCG_A